Parnax Lab Limited (PARNAXLAB.BO)
INR 104.0
(1.96%)
INR 104.0
(1.96%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 243.59 Million INR | -1.84% |
| 2022 | 237.59 Million INR | 2.75% |
| 2021 | 233.6 Million INR | 130.5% |
| 2020 | 100.58 Million INR | 45.85% |
| 2019 | 70.93 Million INR | -42.73% |
| 2018 | 123.3 Million INR | -2.87% |
| 2017 | 109.2 Million INR | -6.74% |
| 2016 | 132.26 Million INR | 26.96% |
| 2015 | 103.36 Million INR | -19.02% |
| 2014 | 125.72 Million INR | 46.3% |
| 2013 | 93.1 Million INR | 6.2% |
| 2012 | 83.78 Million INR | 799.38% |
| 2011 | 9.31 Million INR | 1795.23% |
| 2010 | -549.52 Thousand INR | -126.12% |
| 2009 | -243.01 Thousand INR | -24.53% |
| 2008 | -195.14 Thousand INR | -84.1% |
| 2007 | -106 Thousand INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 86.16 Million INR | 44.45% |
| 2023 Q4 | 57.95 Million INR | -2.88% |
| 2023 Q3 | 59.67 Million INR | 8.33% |
| 2023 FY | - INR | -1.84% |
| 2023 Q1 | 67.39 Million INR | 28.81% |
| 2023 Q2 | 55.08 Million INR | -18.27% |
| 2022 Q4 | 52.32 Million INR | -29.86% |
| 2022 Q2 | 58.59 Million INR | 7.83% |
| 2022 Q3 | 74.59 Million INR | 27.32% |
| 2022 FY | - INR | 2.75% |
| 2022 Q1 | 54.34 Million INR | -24.05% |
| 2021 FY | - INR | 130.5% |
| 2021 Q1 | 34.03 Million INR | 1417.26% |
| 2021 Q2 | 56.18 Million INR | 65.1% |
| 2021 Q3 | 71.21 Million INR | 26.75% |
| 2021 Q4 | 71.55 Million INR | 0.47% |
| 2020 Q4 | -2.58 Million INR | -109.67% |
| 2020 Q2 | 50.03 Million INR | 84.63% |
| 2020 Q3 | 26.72 Million INR | -46.58% |
| 2020 FY | - INR | 45.85% |
| 2020 Q1 | 27.09 Million INR | 319.22% |
| 2019 Q1 | 21.44 Million INR | 79.46% |
| 2019 Q4 | 6.46 Million INR | -51.66% |
| 2019 FY | - INR | -42.73% |
| 2019 Q3 | 13.37 Million INR | -52.5% |
| 2019 Q2 | 28.15 Million INR | 31.27% |
| 2018 Q4 | 11.95 Million INR | -50.61% |
| 2018 Q3 | 24.19 Million INR | -59.66% |
| 2018 Q2 | 59.98 Million INR | 138.82% |
| 2018 Q1 | 25.11 Million INR | -5.43% |
| 2018 FY | - INR | -2.87% |
| 2017 Q2 | 48.92 Million INR | 126.12% |
| 2017 FY | - INR | -6.74% |
| 2017 Q4 | 26.56 Million INR | -4.15% |
| 2017 Q1 | 21.63 Million INR | -8.34% |
| 2017 Q3 | 27.71 Million INR | -43.36% |
| 2016 Q1 | 33.8 Million INR | 62.52% |
| 2016 FY | - INR | 26.96% |
| 2016 Q4 | 23.6 Million INR | -37.21% |
| 2016 Q3 | 37.59 Million INR | 13.59% |
| 2016 Q2 | 33.09 Million INR | -2.09% |
| 2015 Q1 | 27.79 Million INR | -9.08% |
| 2015 FY | - INR | -19.02% |
| 2015 Q3 | 25.46 Million INR | -22.01% |
| 2015 Q2 | 32.65 Million INR | 17.47% |
| 2015 Q4 | 20.79 Million INR | -18.32% |
| 2014 Q1 | 25.62 Million INR | 28.43% |
| 2014 FY | - INR | 46.3% |
| 2014 Q3 | 36.75 Million INR | 7.91% |
| 2014 Q4 | 30.56 Million INR | -16.82% |
| 2014 Q2 | 34.05 Million INR | 32.88% |
| 2013 Q3 | 21.6 Million INR | -26.0% |
| 2013 FY | - INR | 6.2% |
| 2013 Q1 | 25.23 Million INR | 40.55% |
| 2013 Q2 | 29.2 Million INR | 15.71% |
| 2013 Q4 | 19.95 Million INR | -7.64% |
| 2012 Q4 | 17.95 Million INR | -38.91% |
| 2012 Q2 | 15.8 Million INR | -22.5% |
| 2012 FY | - INR | 799.38% |
| 2012 Q3 | 29.39 Million INR | 86.0% |
| 2012 Q1 | 20.38 Million INR | 0.0% |
| 2011 FY | - INR | 1795.23% |
| 2010 FY | - INR | -126.12% |
| 2009 FY | - INR | -24.53% |
| 2008 FY | - INR | -84.1% |
| 2008 Q4 | -146 Thousand INR | 0.0% |
| 2007 FY | - INR | 0.0% |
| 2007 Q4 | -68 Thousand INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| ANG Lifesciences India Limited | 90.66 Million INR | -168.689% |
| Add-Shop E-Retail Limited | 82.61 Million INR | -194.86% |
| Bacil Pharma Limited | -569.32 Thousand INR | 42887.712% |
| BDH Industries Limited | 124.27 Million INR | -96.019% |
| Beryl Drugs Limited | 26.63 Million INR | -814.445% |
| Cian Healthcare Limited | 122.56 Million INR | -98.748% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -1374.749% |
| Concord Drugs Limited | 40.52 Million INR | -501.182% |
| Deccan Health Care Limited | 37.5 Million INR | -549.493% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 9055.846% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -1434.289% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 70.686% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -38036.591% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 35.532% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -1949.117% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 60.095% |
| Panchsheel Organics Limited | 189.36 Million INR | -28.639% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -2002.892% |
| Makers Laboratories Limited | 25.81 Million INR | -843.743% |
| Medi-Caps Limited | 4.77 Million INR | -5005.827% |
| MedPlus Health Services Limited | 3.94 Billion INR | 93.819% |
| Phaarmasia Limited | -1.58 Million INR | 15498.167% |
| Parmax Pharma Limited | 22.93 Million INR | -962.012% |
| Patidar Buildcon Limited | -5.52 Million INR | 4508.234% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | -178.137% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 60099.754% |
| Trident Lifeline Limited | 102.69 Million INR | -137.211% |
| Tyche Industries Limited | 128.2 Million INR | -90.004% |
| Vivanza Biosciences Limited | 11.2 Million INR | -2074.215% |
| PRAVEG LIMITED | 321.43 Million INR | 24.215% |
| Smruthi Organics Limited | 120.31 Million INR | -102.473% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | -443.699% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 4.16% |
| Sastasundar Ventures Limited | -203.51 Million INR | 219.697% |
| Transchem Limited | 56.61 Million INR | -330.303% |
| Trinity League India Limited | -26.25 Million INR | 1027.89% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 37.042% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 852.336% |
| Sunil Healthcare Limited | 93.07 Million INR | -161.712% |
| Syschem (India) Limited | 70.4 Million INR | -246.016% |
| Zenith Healthcare Limited | 4.98 Million INR | -4783.701% |
| Zenlabs Ethica Limited | 27.09 Million INR | -799.022% |
| Mercury Laboratories Limited | 101.18 Million INR | -140.739% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | -173.676% |
| Vasundhara Rasayans Limited | 84.22 Million INR | -189.221% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 261.267% |
| Roopa Industries Limited | 55.7 Million INR | -337.333% |
| PANJON LTD. | 4.08 Million INR | -5857.422% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 297.595% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 1378.601% |
| Anuh Pharma Limited | 878.5 Million INR | 72.271% |
| Crestchem Limited | 30.33 Million INR | -703.047% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 2351.793% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -795.815% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 37.375% |
| Trimurthi Limited | -2.47 Million INR | 9928.445% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | -12.468% |
| Norris Medicines Limited | -1.78 Million INR | 13753.543% |
| Veerhealth Care Limited | 15.99 Million INR | -1422.97% |
| Lactose (India) Limited | 201.22 Million INR | -21.06% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 353.298% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | -42.813% |
| Gennex Laboratories Limited | 219.35 Million INR | -11.051% |
| Denis Chem Lab Limited | 224.84 Million INR | -8.339% |
| Colinz Laboratories Limited | 5.42 Million INR | -4387.822% |
| Godavari Drugs Limited | 134.62 Million INR | -80.946% |
| Zenotech Laboratories Limited | 172.64 Million INR | -41.098% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 45.719% |
| Bharat Parenterals Limited | 265.74 Million INR | 8.333% |
| Coral Laboratories Limited | 227.07 Million INR | -7.276% |
| Evoq Remedies Limited | 6.18 Million INR | -3836.651% |
| Kerala Ayurveda Limited | 70.78 Million INR | -244.13% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 2941.467% |
| Natural Capsules Limited | 219.9 Million INR | -10.777% |
| Auro Laboratories Limited | 121.73 Million INR | -100.104% |